INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Form 4 transactions

21,973 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
34
LC
Longhito ChristopherFMR SVP & CSCO
GICGLOBAL INDUSTRIAL Co
Open-market sale
SELL$62K
1,984 sh
Mar 27, 2026Apr 1, 2026
Page 355 of 550
← PrevNext →
traded Mar 27, 2026
+5d
SEC Form 4

Evidence

32
PK
Puylaert KevinChief Sales Officer
SOPHSOPHiA GENETICS SA
Open-market sale
SELL$14.13
3 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

32
BJ
Buonanno Franck JeanVice-President, Global Sales
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$24K
10.0K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

29
HL
Heard Carlos LawrenceSenior Vice President & CFO
BFSSAUL CENTERS, INC.
Open-market purchase
BUY$10K
500 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

27
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$1.65M
19.5K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

27
CB
Cree BrianPresident & Interim CEO
VTSVitesse Energy, Inc.
Open-market sale
SELL$1.31M
70.1K sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

27
LC
Longhito ChristopherFMR SVP & CSCO
GICGLOBAL INDUSTRIAL Co
Open-market sale
SELL$11K
364 sh
Mar 26, 2026Apr 1, 2026
traded Mar 26, 2026
+6dSEC Form 4

Evidence

27
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$5.02M
59.8K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

26
ZY
Zeng YanChief Financial Officer
ATHMAutohome Inc.
Open-market sale
SELL$12K
2,704 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

26
ND
Noci DarleneChief Development Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$291K
2,968 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

26
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$1.85M
61.3K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

26
XB
Xiang BiboChief Technology Officer
ATHMAutohome Inc.
Open-market sale
SELL$5,314
1,240 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

24
CB
Cree BrianPresident & Interim CEO
VTSVitesse Energy, Inc.
Open-market sale
SELL$926K
50.0K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

24
RB
Read BrianChief Financial Officer
SERVServe Robotics Inc. /DE/
Open-market sale
SELL$10K
1,263 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

24
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$619K
7,232 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

23
ND
Noci DarleneChief Development Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$247K
2,532 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

23
LC
Longhito ChristopherFMR SVP & CSCO
GICGLOBAL INDUSTRIAL Co
Open-market sale
SELL$995
32 sh
Mar 27, 2026Apr 1, 2026
traded Mar 27, 2026
+5dSEC Form 4

Evidence

22
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$1.67M
53.7K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

21
YT
Yaacobi TalDirector
VLNValens Semiconductor Ltd.
Open-market sale
SELL$1,554
1,400 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

20
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.55M
1.00M sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

19
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$1.72M
21.8K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

19
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$196K
6,710 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

16
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.63M
1.00M sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

14
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$21K
4,278 sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

12
BA
Brady James AloysiusDirector
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$60K
10.8K sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

12
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
790 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

9
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$196K
2,366 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$65K
800 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$109K
1,390 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$119K
1,485 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

8
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
4,000 sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

8
BC
Bird Justin ChristopherExecutive Vice President
SRESEMPRA
Open-market sale · 10b5-1 plan
SELL$109K
1,128 sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

3
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
4,000 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

3
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
4,000 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

1
PA
Pena Fernando AustinDirector, President
BXMTBLACKSTONE MORTGAGE TRUST, INC.
Open-market sale · 10b5-1 plan
SELL$31K
1,666 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

51
CE
Carter Charles EdwardChief Regional Officer: Amer.
SBSWSibanye Stillwater Ltd
Open-market purchase
BUY$114K
10.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

50
MR
Morgan RachelEVP General Counsel
NXSTNEXSTAR MEDIA GROUP, INC.
Open-market sale
SELL$668K
3,127 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

50
WS
Weaver Robert S.EVP, Government Relations
NXSTNEXSTAR MEDIA GROUP, INC.
Open-market sale
SELL$399K
1,872 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

47
YF
Yeap Choh FeiSVP
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTD
Open-market purchase
BUY$56K
1,000 sh
Mar 22, 2026Mar 31, 2026
traded Mar 22, 2026
+9dSEC Form 4

Evidence

47
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$434K
2,161 sh
Mar 6, 2026Mar 31, 2026
traded Mar 6, 2026
+25dSEC Form 4

Evidence

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K